Information  X 
Enter a valid email address

SYNCONA (SYNC)

Date Time Source Announcement
30 Jun 2022 9:00 am
RNS
Publication of 2022 Annual Report & Notice of AGM
22 Jun 2022 5:21 pm
RNS
Director Declaration
16 Jun 2022 7:00 am
RNS
Final Results
10 Jun 2022 8:05 am
RNS
Autolus presents clinical data updates at EHA
08 Jun 2022 2:33 pm
RNS
Holding(s) in Company
19 May 2022 7:00 am
RNS
Notice of Results
18 May 2022 11:05 am
RNS
Syncona invests in $56 million SwanBio Series B
12 May 2022 4:00 pm
RNS
Autolus to present clinical data at EHA Congress
11 May 2022 7:00 am
RNS
Freeline reports Q1 2022 Financial Results
10 May 2022 1:02 pm
RNS
Achilles reports Q1 2022 Financial Results
05 May 2022 12:05 pm
RNS
Autolus Reports Q1 2022 Financial Results
28 Apr 2022 7:00 am
RNS
Syncona invests in �75.5 million OMass Series B
11 Apr 2022 7:00 am
RNS
Anaveon announces initial clinical data
04 Apr 2022 12:34 pm
RNS
Director/PDMR Shareholding
01 Apr 2022 7:00 am
RNS
Freeline reports Full Year 2021 Financial Results
24 Mar 2022 4:11 pm
RNS
Holding(s) in Company
23 Mar 2022 8:30 am
RNS
Freeline enters into ADS purchase agreement
11 Mar 2022 7:00 am
RNS
Freeline registered direct offering
10 Mar 2022 12:05 pm
RNS
Autolus Reports Full Year 2021 Financial Results
09 Mar 2022 4:39 pm
RNS
Director/PDMR Shareholding
  3:09 pm
RNS
Holding(s) in Company
07 Mar 2022 5:29 pm
RNS
Director/PDMR Shareholding
01 Mar 2022 12:56 pm
RNS
Achilles reports Full Year 2021 Results
18 Feb 2022 7:00 am
RNS
Completion of sale of Gyroscope Therapeutics
10 Feb 2022 7:00 am
RNS
3rd Quarter Results
08 Feb 2022 12:05 pm
RNS
Freeline presents data in Fabry disease
31 Dec 2021 7:00 am
RNS
Directorate Change
22 Dec 2021 7:00 am
RNS
Gyroscope to be acquired for up to $1.5 billion
16 Dec 2021 7:00 am
RNS
Syncona cornerstones Anaveon Series B
14 Dec 2021 7:00 am
RNS
Freeline reports 2022 priorities and guidance
13 Dec 2021 2:05 pm
RNS
Freeline presents data in haemophilia B
  12:05 pm
RNS
Autolus presents positive AUTO1 (obe-cel) data
29 Nov 2021 7:00 am
RNS
Syncona co-leads Series B financing in Quell
22 Nov 2021 7:00 am
RNS
Syncona appoints new Directors
12 Nov 2021 1:56 pm
RNS
Achilles Presents Data at the SITC Annual Meeting
11 Nov 2021 7:00 am
RNS
Half-year Report
10 Nov 2021 7:00 am
RNS
Freeline reports new data and 3rd Quarter Results
09 Nov 2021 1:31 pm
RNS
Achilles reports Third Quarter Financial Results
08 Nov 2021 1:05 pm
RNS
Gyroscope Announces Sanofi Equity Investment
  7:00 am
RNS
Blackstone Life Science to invest $250m in Autolus
03 Nov 2021 11:07 am
RNS
Syncona leads $87 million financing of Clade
  11:05 am
RNS
Autolus reports Q3 2021 Financial Results
26 Oct 2021 7:00 am
RNS
Notice of Results
30 Sep 2021 3:59 pm
RNS
Gyroscope announces additional positive data
17 Aug 2021 7:00 am
RNS
First Quarter Update
16 Aug 2021 12:07 pm
RNS
Freeline Reports Executive Change and Q2 Results
10 Aug 2021 12:05 pm
RNS
Achilles reports Second Quarter 2021 Results
05 Aug 2021 12:05 pm
RNS
Autolus reports Q2 2021 Financial Results
03 Aug 2021 1:16 pm
RNS
Result of AGM - Replacement
30 Jul 2021 12:17 pm
RNS
Total Voting Rights
27 Jul 2021 2:41 pm
RNS
Holding(s) in Company
15 Jul 2021 12:57 pm
RNS
Issue of shares pursuant to incentive scheme
01 Jul 2021 11:54 am
RNS
Publication of 2021 Annual Report & Notice of AGM
24 Jun 2021 7:00 am
RNS
Anaveon doses first patient in Phase I/II study
17 Jun 2021 7:00 am
RNS
Final Results
  7:00 am
RNS
Syncona announces expansion of leadership team
11 Jun 2021 12:05 pm
RNS
Autolus to present additional data in AUTO1
18 May 2021 7:00 am
RNS
Notice of Results
  7:00 am
RNS
Freeline reports Q1 results

a d v e r t i s e m e n t